SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Lowered by Advantage Trust Co

Advantage Trust Co lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 4,645 shares of the exchange traded fund’s stock after selling 1,200 shares during the quarter. Advantage Trust Co’s holdings in SPDR S&P Biotech ETF were worth $418,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $29,000. Avior Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares during the period. Tidemark LLC increased its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $91.70 on Friday. The company has a 50 day moving average price of $91.36 and a 200 day moving average price of $95.97. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The firm has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.